Company Profile
Vera Therapeutics Stock Price, News & Analysis
- Ticker:
- VERA
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- United States
Stock performance
36.99 USD (+18.33%)
Close
Last updated: July 20, 2026
2.24B USD
Market cap
Why the stock is moving
VERA is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Vera Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Vera Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Vera Therapeutics follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Vera Therapeutics sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
- 02
Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA
BMY · Source: BMYBristol-Myers Squibb Company
- 03
- 04
Fresenius Medical Care introduces TherapyWise™ analytics for kidney replacement therapy
FMS · Source: Fresenius Medical Care Ventures
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Vera Therapeutics (VERA)?
Vera Therapeutics (VERA) most recently closed at 36.99 USD, a +18.33% move versus the previous session.
What is the market cap of Vera Therapeutics (VERA)?
Vera Therapeutics currently has a market capitalization of 2.24B USD on BioPharmSignal.
What does Vera Therapeutics do?
Vera Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is VERA stock listed?
Vera Therapeutics (VERA) is associated with NASDAQ, United States, Biotechnology.
What is Vera?
Vera Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Vera Therapeutics targeting with Vera?
Vera Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Therapeutics?
Vera Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.